FM GENERAL TRADING LTD

Zepbound (tirzepatide) is a once-weekly injectable prescription medication used for chronic weight management and to treat moderate-to-severe obstructive sleep apnea. It is prescribed alongside a reduced-calorie diet and increased physical activity for adults with obesity or those who are overweight with weight-related medical conditions  

• Starter Dose: You typically begin at 2.5 mg once a week for the first four weeks.
• Escalation: The dose is gradually increased every four weeks to minimize side effects.
• Maintenance: Common target doses are 5 mg, 10 mg, or 15 mg once weekly.